View More Recent Stories

Sep 15, 2020 04:05PM Alpine Immune Sciences to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Sep 8, 2020 04:05PM Alpine Immune Sciences to Present at H.C. Wainwright 22nd Annual Global Investment Conference
Aug 11, 2020 04:05PM Alpine Immune Sciences Reports Second Quarter 2020 Financial Results and Provides Corporate Update
Aug 5, 2020 04:05PM Alpine Immune Sciences to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference
Aug 4, 2020 04:05PM Alpine Immune Sciences to Report Second Quarter 2020 Financial Results and Provide Corporate Update
Jul 24, 2020 09:15AM Alpine Immune Sciences Announces $60 Million Private Placement
Jun 24, 2020 08:01AM Alpine Immune Sciences (ALPN) Reports First Patient Dosed in NEON-1 Phase 1 Trial of ALPN-202 in Patients with Advanced Malignancies
Jun 24, 2020 08:00AM Alpine Immune Sciences Announces First Patient Dosed in NEON-1 Phase 1 Trial of ALPN-202 in Patients with Advanced Malignancies
Jun 18, 2020 08:01AM Alpine Immune Sciences (ALPN), AbbVie (ABBV) Announce Option and License Agreement for Development and Commercialization of ALPN-101
Jun 18, 2020 08:00AM Alpine Immune Sciences and AbbVie Announce Option and License Agreement for the Development and Commercialization of ALPN-101
View More Recent Stories